Showing 1 - 6 results of 6 for search 'Kim Monkhorst', query time: 0.02s
Refine Results
-
1
-
2
The probability to initiate X chromosome inactivation is determined by the X to autosomal ratio and X chromosome specific allelic properties. by Kim Monkhorst, Bas de Hoon, Iris Jonkers, Eskeatnaf Mulugeta Achame, Wouter Monkhorst, Jos Hoogerbrugge, Eveline Rentmeester, Hans V Westerhoff, Frank Grosveld, J Anton Grootegoed, Joost Gribnau
Published 2009-01-01Get full text
Article -
3
Biological and technical factors in the assessment of blood-based tumor mutational burden (bTMB) in patients with NSCLC by Kim Monkhorst, Daniel Klass, Milou Schuurbiers, Zhongyun Huang, Senglor Saelee, Manana Javey, Leonie de Visser, Daan van den Broek, Michel van den Heuvel, Alexander F Lovejoy
Published 2022-02-01Get full text
Article -
4
External validation of a serum tumor marker algorithm for early prediction of no durable benefit to immunotherapy in metastastic non-small cell lung carcinoma by Milou M. F. Schuurbiers, Freek A. van Delft, Hendrik Koffijberg, Maarten J. IJzerman, Kim Monkhorst, Marjolijn J. L. Ligtenberg, Daan van den Broek, Huub H. van Rossum, Michel M. van den Heuvel
Published 2025-02-01Get full text
Article -
5
Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL products by Suzanne M. Castenmiller, Nandhini Kanagasabesan, Aurélie Guislain, Benoît P. Nicolet, Marleen M. van Loenen, Kim Monkhorst, Alexander A.F.A. Veenhof, Egbert F. Smit, Koen J. Hartemink, John B.A.G. Haanen, Rosa de Groot, Monika C. Wolkers
Published 2024-12-01Get full text
Article -
6
Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study. by Milou M F Schuurbiers, Christopher G Smith, Koen J Hartemink, Robert C Rintoul, Davina Gale, Kim Monkhorst, Bas L R Mandos, Anna L Paterson, Daan van den Broek, Nitzan Rosenfeld, Michel M van den Heuvel, LEMA Study Group and the LUCID Study Group
Published 2025-04-01Get full text
Article